Conversely, the ubiquitination E3-ligase RNF168 has been shown to cooperate with another E3 ubiquitin-protein ligase RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer response to epirubicin treatment [57]. The gene discussed is FOXM1; the disease is breast carcinoma.